当前位置:首页 - 行情中心 - 羚锐制药(600285) - 财务分析

羚锐制药

(600285)

  

流通市值:127.38亿  总市值:127.66亿
流通股本:5.66亿   总股本:5.67亿

羚锐制药(600285)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至第三季度实现净利润6.54亿元,每股收益1.15元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至第三季度最新股东权益328328.53万元,未分配利润204401.44万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至第三季度最新总资产575568.77万元,负债247240.24万元。

利润表
报告期2025-09-302025-06-302025-03-312024-12-31
营业总收入3,041,361,639.172,099,205,515.811,020,755,870.553,500,831,286.92
营业总成本2,332,076,667.211,580,082,239.98780,335,122.232,768,148,768.85
其他经营收益
营业利润758,364,587.13551,471,072.75253,684,137.59810,301,684.55
利润总额757,558,792.81551,547,542.75253,668,892.56827,572,996.86
净利润653,536,523.2475,868,499.88216,733,789.1722,584,691.99
每股收益
其他综合收益4,885,283.796,235,719.576,311,122.23-52,945,072.92
综合收益总额658,421,806.99482,104,219.45223,044,911.33669,639,619.07
资产负债表
报告期2025-09-302025-06-302025-03-312024-12-31
流动资产:
流动资产合计2,574,106,317.52,346,584,704.862,004,404,855.72,458,038,247.11
非流动资产:
非流动资产合计3,181,581,407.383,225,642,764.743,406,490,925.222,558,804,960.62
资产总计5,755,687,724.885,572,227,469.65,410,895,780.925,016,843,207.73
流动负债:
流动负债合计2,393,537,389.612,393,949,476.051,986,108,168.891,874,335,175.06
非流动负债:
非流动负债合计78,865,018.2377,969,701.1580,919,127.4662,215,968.67
负债合计2,472,402,407.842,471,919,177.22,067,027,296.351,936,551,143.73
所有者权益(或股东权益):
归属于母公司股东权益合计3,248,239,730.073,066,393,164.323,311,522,505.913,072,526,287.29
股东权益合计3,283,285,317.043,100,308,292.43,343,868,484.573,080,292,064
负债和股东权益合计5,755,687,724.885,572,227,469.65,410,895,780.925,016,843,207.73
现金流量表
报告期2025-09-302025-06-302025-03-312024-12-31
经营活动产生的现金流量:
经营活动现金流入小计3,108,738,229.972,069,419,931.08903,232,099.553,924,835,712.29
经营活动现金流出小计2,618,350,573.611,713,832,424.33785,616,199.433,048,971,479.16
经营活动产生的现金流量净额490,387,656.36355,587,506.75117,615,900.12875,864,233.13
投资活动产生的现金流量:
投资活动现金流入小计722,196,602.94194,001,683.84159,012,139.42465,877,124.38
投资活动现金流出小计1,916,478,880.541,122,660,675.1944,785,928.441,131,709,447.72
投资活动产生的现金流量净额-1,194,282,277.6-928,658,991.26-785,773,789.02-665,832,323.34
筹资活动产生的现金流量:
筹资活动现金流入小计517,374,558.27398,070,362.2911,340,271.8984,193,548.64
筹资活动现金流出小计582,179,320.3521,038,763.95617,588.12556,131,430.6
筹资活动产生的现金流量净额-64,804,762.03-122,968,401.6610,722,683.77-471,937,881.96
汇率变动对现金及现金等价物的影响-22,131.92-18,920.46-12,982.27,770.61
现金及现金等价物净增加额-768,721,515.19-696,058,806.63-657,448,187.33-261,898,201.56
期末现金及现金等价物余额459,656,290.81532,318,999.37570,929,618.671,228,377,806
补充资料:
现金及现金等价物的净增加额--696,058,806.63--261,898,201.56
最新报告期:2025-11-03
研究机构分析师预测每股收益(元)更新日
2025年2026年2027年
长城证券刘鹏,袁紫馨1.451.631.822025-11-03
浙商证券丁健行,吴天昊1.481.671.872025-10-30
浙商证券丁健行,吴天昊1.481.671.872025-08-25
东海证券杜永宏1.461.681.902025-08-22
长城证券刘鹏,袁紫馨1.461.681.882025-08-20
TOP↑